Literature DB >> 25846475

Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm.

Chao Zhang1, Xiangmei Chen2, Hui Liu3, Hui Li1, Wei Jiang1, Wenting Hou1, Michael A McNutt4, Fengmin Lu2, Gang Li1,5.   

Abstract

Although tumor-associated fetal protein AFP has demonstrated utility as a clinical tumor marker, the significance of intracellular AFP is still unclear. The aim of this study was to explore the role of cytoplasmic AFP during HBx induced carcinogenesis, which had not previously been recognized; 614 HCC patients were analyzed for correlation of HBV infection with AFP level, and much higher AFP levels were found in HBsAg positive patients. Tumor tissue specimens from 20 HCC patients were used for analysis of AFP and GADD45α. Analysis of HCC specimens showed that upregulation of cytoplasmic AFP is associated with down-regulation of GADD45α in neoplastic tissue. Transfected HBx promotes transcription of AFP by acting on the elements in the AFP gene regulatory region. HBx itself did not directly impact transcription of GADD45α. However, the obstruction of RAR signaling by HBx induced elevation of AFP, which led to down-regulation of GADD45α. Cytoplasmic AFP was able to interact with RAR, disrupting its entrance into the nucleus and binding to the elements in the regulatory region of the GADD45α gene. Knockdown of AFP in siRNA-transfected AFP positive cell lines was synchronously associated with an incremental increase of RAR binding to DNA, as well as upregulation of GADD45α and it was contrary in AFP gene-transfected AFP negative cell lines. These results indicate cytoplasmic AFP is not only a histochemical tumor biomarker for human hepatoma but is also an intracellular signal molecule and potential participant in HBx induced hepatocarcinogenesis.
© 2015 UICC.

Entities:  

Keywords:  HBV; all trans retinoic acid; alpha fetoprotein; carcinogenesis; growth arrest and DNA damage 45α; nuclear receptor

Mesh:

Substances:

Year:  2015        PMID: 25846475     DOI: 10.1002/ijc.29548

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Nonsecreted cytoplasmic alpha-fetoprotein: a newly discovered role in intracellular signaling and regulation. An update and commentary.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2015-07-12

2.  The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2016-07-22

Review 3.  Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells.

Authors:  Oleg Shuvalov; Alyona Kizenko; Alexey Petukhov; Olga Fedorova; Alexandra Daks; Nikolai Barlev
Journal:  Cell Death Discov       Date:  2021-05-08

4.  Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.

Authors:  Mingjie Yao; Jingmin Zhao; Fengmin Lu
Journal:  Oncotarget       Date:  2016-01-26

5.  Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary.

Authors:  Gerald J Mizejewski
Journal:  J Hepatocell Carcinoma       Date:  2016-09-21

Review 6.  Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma.

Authors:  Mankgopo M Kgatle; Mashiko Setshedi; Henry N Hairwadzi
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

7.  CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.

Authors:  Yongzhen Liu; Xuewei Qi; Zhenzhen Zeng; Lu Wang; Jie Wang; Ting Zhang; Qiang Xu; Congle Shen; Guangde Zhou; Shaomin Yang; Xiangmei Chen; Fengmin Lu
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

8.  Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.

Authors:  Chao Zhang; Hui Li; Wei Jiang; Xiaowei Zhang; Gang Li
Journal:  Oncotarget       Date:  2016-12-13

9.  A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.

Authors:  Hiroki Nishikawa; Norihiro Nishijima; Hirayuki Enomoto; Azusa Sakamoto; Akihiro Nasu; Hideyuki Komekado; Takashi Nishimura; Ryuichi Kita; Toru Kimura; Hiroko Iijima; Shuhei Nishiguchi; Yukio Osaki
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

10.  Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells.

Authors:  Mingyue Zhu; Yan Lu; Wei Li; Junli Guo; Xu Dong; Bo Lin; Yi Chen; Xieju Xie; Mengsen Li
Journal:  J Cancer       Date:  2016-05-12       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.